B12 Levels Relate to Dietary Source in Framingham Study
Tucker KL et al. • Am J Clin Nutr
Key Finding
39% of adults have B12 levels below 350 pg/mL
Original title: “Plasma vitamin B-12 concentrations relate to intake source in the Framingham Offspring study”
Plain English Summary
Framingham Offspring Study analysis showing 39% of adults have B12 levels below 350 pg/mL, with plasma B12 strongly related to dietary intake source.
In-Depth Analysis
Background
Dr. Katherine L. Tucker and colleagues from the USDA Human Nutrition Research Center published this study in the American Journal of Clinical Nutrition (PMID: 10648266), examining B12 status in the Framingham Offspring cohort.
Study Design
Design: Cross-sectional analysis of Framingham Offspring Study Population: 2,999 adults aged 26-83 years Measurements: Plasma B12, dietary intake by food frequency questionnaire Analysis: B12 status by age group and dietary intake source
Key Findings
B12 status by level:
| B12 Level (pg/mL) | Prevalence |
|---|---|
| <200 | 9% |
| 200-350 | 30% |
| >350 | 61% |
Total prevalence of low/marginal B12: 39% of adults
B12 by dietary source:
| Source | Effect on B12 |
|---|---|
| Fortified cereals | Strongest positive |
| Dairy | Positive |
| Meat | Modest positive |
| Supplements | Strong positive |
Key finding: B12 from meat was less bioavailable than from fortified foods, especially in older adults.
Mechanistic Insights
Age-related decline in B12 status reflects:
- •Gastric atrophy reducing intrinsic factor
- •Reduced gastric acid (needed to release food-bound B12)
- •Medications (PPIs, metformin) further impairing absorption
- •Crystalline B12 (supplements, fortified foods) absorbed independently
Clinical Implications
39% of adults have suboptimal B12 status. Older adults may absorb supplemental B12 better than food-bound B12. Regular monitoring warranted, especially in elderly.
Metabolic Health Perspective
This Framingham data established population-level B12 insufficiency. For metabolic optimization, levels >500 pg/mL provide a margin of safety for neurological protection.
Paradigm Relevance
How this study applies to different clinical perspectives:
Standard Medical
RelevantConventional clinical guidelines used by most doctors
Research Consensus
RelevantCurrent scientific understanding, often ahead of guidelines
Metabolic Optimization
RelevantProactive targets for optimal health, not just disease absence
Study Details
- Type
- research.studyTypes.observational
Topic
Related Biomarkers
Calculate & Evaluate on Metabolicum
Original Source
Related Studies
Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications
Miller JW • Advances in Nutrition • 2018
PPIs/H2RAs: HR 1.83 (95% CI 1.36-2.46) for B12 deficiency with ≥10 months use; Metformin: mean B12 reduction of -54 pmol/L (95% CI -81 to -26)
Clinical Guidelines for B12 Deficiency Recognition and Management
Langan RC, Goodbred AJ • Am Fam Physician • 2017
Neurological protection requires B12 levels above 500 pg/mL
Comprehensive Review of Vitamin B12 Deficiency
Stabler SP • N Engl J Med • 2013
MMA testing identifies tissue-level deficiency missed by serum B12